In patients with type 2 diabetes and CKD, finerenone improved CV and kidney outcomes.
Mayne KJ., Herrington WG.
Source citationAgarwal R, Filippatos G, Pitt B, et al. Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis. Eur Heart J. 2022;43:474-84. 35023547.